Santo Domingo, Dominican Republic — The International Society for Stem Cell Application (ISSCA) announces its return to the Dominican Republic with the International Congress in Regenerative Medicine – ISSCA Dominican Republic 2026, taking place on May 8–9, 2026, in Santo Domingo. This new edition marks a significant evolution from ISSCA’s previous presence in the country in August 2024, returning now with a larger, more comprehensive event designed to meet the growing regional demand for advanced education, certification, and global collaboration in regenerative medicine.
Following the success and strong engagement of its last event in the Dominican Republic, ISSCA is expanding both the scientific scope and institutional impact of its 2026 congress. The organization’s return reflects the rapid maturation of the local medical community and the country’s increasing relevance as a strategic meeting point for physicians from the Caribbean, Central America, and Latin America.
“The Dominican Republic has demonstrated strong momentum in regenerative and integrative medicine,” said Benito Novas, Founder of ISSCA.
“Our return in 2026 represents a natural next step—bringing a larger scientific program, expanded certifications, and a global platform that connects local physicians with international leaders and best practices.”
A Growing Regional Platform for Advanced Medical Education
Over the past few years, the Dominican Republic has emerged as a regional destination for wellness, aesthetic medicine, and advanced clinical care. Physicians are increasingly seeking structured education and internationally validated standards to safely integrate regenerative therapies into their practices.
ISSCA Dominican Republic 2026 is designed to respond to this evolution, offering a high-level educational experience that supports:
- The professionalization of regenerative medicine in the Caribbean
- Access to global scientific standards and protocols
- Integration of evidence-based therapies into private and institutional practice
- Regional collaboration among Spanish-speaking medical communities
The congress will convene international faculty and regional leaders to explore the future of regenerative and precision medicine.
Scientific Program and Certifications
The two-day event will feature a comprehensive scientific agenda addressing key areas shaping modern regenerative medicine, including:
- Cellular and regenerative therapies
- Peptide-based clinical strategies
- Longevity and metabolic optimization
- Inflammation control and tissue repair
- Integrative approaches to aesthetic and functional medicine
ISSCA will also offer its internationally recognized certification programs, providing physicians with formal training and validation aligned with global standards. These certifications are designed to support clinicians seeking to elevate patient safety, clinical outcomes, and professional positioning.
Creating Connections Beyond the Classroom
Beyond its academic content, ISSCA Dominican Republic 2026 will create curated environments that encourage meaningful professional interaction. Physicians will have the opportunity to connect with peers, faculty, and industry leaders, exchange clinical insights, and explore collaborative initiatives that extend beyond the event itself.
This convergence of education and networking reflects ISSCA’s broader mission: to serve as a global platform where medical leaders connect, collaborate, and grow together.
A Strategic Return with Expanded Impact
ISSCA’s return to the Dominican Republic signals more than continuity—it represents growth. With a larger audience, expanded certifications, and increased international participation, the 2026 congress reinforces the country’s role as a regional hub for regenerative medicine education.
By bringing advanced training and global standards back to Santo Domingo, ISSCA aims to support the next stage of development for physicians across the Caribbean and Latin America, fostering a medical ecosystem grounded in science, collaboration, and responsible innovation.
Physicians and healthcare professionals interested in attending ISSCA Dominican Republic 2026 (May 8–9) can register at:
Early registration benefits include:
- Special Early-Bird pricing
- Priority access to certification programs
- Admission to MedConnect Brasil
- Pre-event educational materials and digital resources
About ISSCA
“The International Society for Stem Cell Application (ISSCA) is a leading organization in the field of regenerative medicine. It is dedicated to advancing the science and practice of stem cell therapy and regenerative medicine through education, certification, research, and training. ISSCA provides certification training in cities worldwide, recognizing the importance of standards and certifications in regenerative medicine as a medical specialty.”
About Global Stem Cells Group
“Global Stem Cells Group is a leading provider of regenerative medicine solutions, dedicated to advancing healthcare through innovative therapies. With a global presence and a multidisciplinary team of experts, the organization strives to harness the potential of stem cells and regenerative medicine to improve patient outcomes across various medical fields. Through its extensive network of clinics, research facilities, and training centers, Global Stem Cells Group is committed to pushing the boundaries of regenerative medicine and making a positive impact on global healthcare.”
Safe Harbor Statement
Statements in this news release may be “forward-looking statements.” Forward-looking statements include, but are not limited to, statements that express our intentions, beliefs, expectations, strategies, predictions, or any other information relating to our future activities or other future events or conditions. These statements are based on current expectations, estimates, and projections about our business, partly based on assumptions made by management. These statements are not guarantees of future performance and involve risks, uncertainties, and assumptions that are difficult to predict. Therefore, actual outcomes and results may differ materially from what is expressed or forecasted in forward-looking statements due to numerous factors. Any forward-looking statements speak only as of the date of this news release, and The Global Stem Cells Group undertakes no obligation to update any forward-looking statement to reflect events or circumstances after the date of this news release. This press release does not constitute a public offer of any securities for sale. Any securities offered privately will not be or have not been registered under the Act and may not be offered or sold in the United States absent registration or an applicable exemption from registration requirements.
